American Heart Association
Emerging Opportunities for Managing Cardiometabolic Syndrome
Featured Science
Clinical Science Zone 1, Moderated Digital Poster 5
Nov 9th , 03:15 PM - 04:30 PM
03 : 15 PM
Arterial Stiffness Mechanisms and Orthostatic Hypotension in The Systolic Blood Pressure Intervention Trial
Gepner Adam, Jaeger Byron, Hughes Timothy, Upadhya Bharathi, Kitzman Dalane, Supiano Mark, Pewowaruk Ryan
Final Pr. ID: -
Authors: Gepner Adam, Jaeger Byron, Hughes Timothy, Upadhya Bharathi, Kitzman Dalane, Supiano Mark, Pewowaruk Ryan
Keywords: Hypertension , Blood pressure , Blood vessel wall , Cardiovascular health , Healthcare innovation
03 : 24 PM
KARDIA-3: A randomized trial of zilebesiran versus placebo on top of standard care for patients with hypertension and established cardiovascular disease or high cardiovascular risk with or without chronic kidney disease
Pagidipati Neha, Bhan Ishir, Granger Christopher, Weber Michael, Saxena Manish, Williams Bryan, Goodman Shaun, Xiang Zhihua, Daga Shruti, Bengus Monica, Zappe Dion
Final Pr. ID: -
Authors: Pagidipati Neha, Bhan Ishir, Granger Christopher, Weber Michael, Saxena Manish, Williams Bryan, Goodman Shaun, Xiang Zhihua, Daga Shruti, Bengus Monica, Zappe Dion
Keywords: Clinical trials , Hypertension , Antihypertensive agents , Cardiovascular disease prevention , Chronic Kidney Disease
03 : 33 PM
Effect of Baxdrostat on 24-Hour Average Ambulatory Blood Pressure in Patients with Resistant Hypertension: The Bax24 Trial
Flack John, Shibata Hirotaka, Wang Ji-guang, Wittes Janet, Williams Bryan, Azizi Michel, Brown Jenifer, Dwyer Jamie, Jones Erika, Kurlyandskaya Raisa, Lihn Aina, Li Hongjian, Perl Shira
Final Pr. ID: -
Authors: Flack John, Shibata Hirotaka, Wang Ji-guang, Wittes Janet, Williams Bryan, Azizi Michel, Brown Jenifer, Dwyer Jamie, Jones Erika, Kurlyandskaya Raisa, Lihn Aina, Li Hongjian, Perl Shira
Keywords: Resistant hypertension , Aldosterone , Blood pressure
03 : 42 PM
Once-weekly tirzepatide versus dulaglutide on major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease
Nicholls Stephen, Dalessio David
Final Pr. ID: -
Authors: Nicholls Stephen, Dalessio David
Keywords: Cardiovascular disease , Coronary artery bypass grafting (CABG) , Percutaneous coronary intervention (PCI) , Diabetes (Type II)
Kruger Nils, Schneeweiss Sebastian, Wang Shirley, Investigators Rct-duplicate
Final Pr. ID: -
Authors: Kruger Nils, Schneeweiss Sebastian, Wang Shirley, Investigators Rct-duplicate
Keywords: Obesity , Diabetes Mellitus , Myocardial infarction , Mortality , Stroke
04 : 00 PM
Enlicitide, an oral PCSK9 inhibitor, in participants with heterozygous familial hypercholesterolemia: a double-blind, Phase 3, randomized placebo-controlled trial
Ballantyne Christie, Wang Fan, Gellis Laura, Catapano Alberico, Tardif Jean-claude, Navar Ann Marie, Banka Puja, Asprusten Emil, Scott Russell, Stroes Erik, Froman Samar, Mendizabal Geraldine
Final Pr. ID: -
Authors: Ballantyne Christie, Wang Fan, Gellis Laura, Catapano Alberico, Tardif Jean-claude, Navar Ann Marie, Banka Puja, Asprusten Emil, Scott Russell, Stroes Erik, Froman Samar, Mendizabal Geraldine
Keywords: PCSK9 , LDL , Hyperlipidemia , Atherosclerosis , Cardiovascular disease prevention
04 : 09 PM
Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial
Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan
Final Pr. ID: -
Authors: Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan
Keywords: PCSK9 , LDL , Dyslipidemia
Powell Lynda, Zimmermann Laura, Suzuki Sumihiro, Berkley-patton Jannette, Drees Betty, Karavolos Kelly, Lohse Barbara, Masters Kevin, Nicklas Jacinda, Rothschild Steven K., Yeh Chen
Final Pr. ID: -
Authors: Powell Lynda, Zimmermann Laura, Suzuki Sumihiro, Berkley-patton Jannette, Drees Betty, Karavolos Kelly, Lohse Barbara, Masters Kevin, Nicklas Jacinda, Rothschild Steven K., Yeh Chen
Keywords: Metabolic syndrome , Efficacy , Clinical trials , Lifestyle , Behavioral medicine
03 : 15 PM
Arterial Stiffness Mechanisms and Orthostatic Hypotension in The Systolic Blood Pressure Intervention Trial
Gepner Adam, Jaeger Byron, Hughes Timothy, Upadhya Bharathi, Kitzman Dalane, Supiano Mark, Pewowaruk Ryan
Final Pr. ID: -
Authors: Gepner Adam, Jaeger Byron, Hughes Timothy, Upadhya Bharathi, Kitzman Dalane, Supiano Mark, Pewowaruk Ryan
Keywords: Hypertension , Blood pressure , Blood vessel wall , Cardiovascular health , Healthcare innovation
Kruger Nils, Schneeweiss Sebastian, Wang Shirley, Investigators Rct-duplicate
Final Pr. ID: -
Authors: Kruger Nils, Schneeweiss Sebastian, Wang Shirley, Investigators Rct-duplicate
Keywords: Obesity , Diabetes Mellitus , Myocardial infarction , Mortality , Stroke
03 : 33 PM
Effect of Baxdrostat on 24-Hour Average Ambulatory Blood Pressure in Patients with Resistant Hypertension: The Bax24 Trial
Flack John, Shibata Hirotaka, Wang Ji-guang, Wittes Janet, Williams Bryan, Azizi Michel, Brown Jenifer, Dwyer Jamie, Jones Erika, Kurlyandskaya Raisa, Lihn Aina, Li Hongjian, Perl Shira
Final Pr. ID: -
Authors: Flack John, Shibata Hirotaka, Wang Ji-guang, Wittes Janet, Williams Bryan, Azizi Michel, Brown Jenifer, Dwyer Jamie, Jones Erika, Kurlyandskaya Raisa, Lihn Aina, Li Hongjian, Perl Shira
Keywords: Resistant hypertension , Aldosterone , Blood pressure
04 : 00 PM
Enlicitide, an oral PCSK9 inhibitor, in participants with heterozygous familial hypercholesterolemia: a double-blind, Phase 3, randomized placebo-controlled trial
Ballantyne Christie, Wang Fan, Gellis Laura, Catapano Alberico, Tardif Jean-claude, Navar Ann Marie, Banka Puja, Asprusten Emil, Scott Russell, Stroes Erik, Froman Samar, Mendizabal Geraldine
Final Pr. ID: -
Authors: Ballantyne Christie, Wang Fan, Gellis Laura, Catapano Alberico, Tardif Jean-claude, Navar Ann Marie, Banka Puja, Asprusten Emil, Scott Russell, Stroes Erik, Froman Samar, Mendizabal Geraldine
Keywords: PCSK9 , LDL , Hyperlipidemia , Atherosclerosis , Cardiovascular disease prevention
03 : 24 PM
KARDIA-3: A randomized trial of zilebesiran versus placebo on top of standard care for patients with hypertension and established cardiovascular disease or high cardiovascular risk with or without chronic kidney disease
Pagidipati Neha, Bhan Ishir, Granger Christopher, Weber Michael, Saxena Manish, Williams Bryan, Goodman Shaun, Xiang Zhihua, Daga Shruti, Bengus Monica, Zappe Dion
Final Pr. ID: -
Authors: Pagidipati Neha, Bhan Ishir, Granger Christopher, Weber Michael, Saxena Manish, Williams Bryan, Goodman Shaun, Xiang Zhihua, Daga Shruti, Bengus Monica, Zappe Dion
Keywords: Clinical trials , Hypertension , Antihypertensive agents , Cardiovascular disease prevention , Chronic Kidney Disease
Powell Lynda, Zimmermann Laura, Suzuki Sumihiro, Berkley-patton Jannette, Drees Betty, Karavolos Kelly, Lohse Barbara, Masters Kevin, Nicklas Jacinda, Rothschild Steven K., Yeh Chen
Final Pr. ID: -
Authors: Powell Lynda, Zimmermann Laura, Suzuki Sumihiro, Berkley-patton Jannette, Drees Betty, Karavolos Kelly, Lohse Barbara, Masters Kevin, Nicklas Jacinda, Rothschild Steven K., Yeh Chen
Keywords: Metabolic syndrome , Efficacy , Clinical trials , Lifestyle , Behavioral medicine
04 : 09 PM
Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial
Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan
Final Pr. ID: -
Authors: Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan
Keywords: PCSK9 , LDL , Dyslipidemia
03 : 42 PM
Once-weekly tirzepatide versus dulaglutide on major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease
Nicholls Stephen, Dalessio David
Final Pr. ID: -
Authors: Nicholls Stephen, Dalessio David
Keywords: Cardiovascular disease , Coronary artery bypass grafting (CABG) , Percutaneous coronary intervention (PCI) , Diabetes (Type II)